CLINICAL TRIALS

Phase 0/1 dose-escalation trial to determine the maximum tolerated dose of Mycophenolate Mofetil (MMF) when administered to patients with recurrent glioblastoma or recurrent gliosarcoma. 

Assessment of Metabolic Pathway Activity in Patients with Brain Tumors using Stable Isotope Tracing

Phase 0/1 clinical trial of environmental serine depletion (in development)